Drug used in RSV infection in children
Palivizumab is a chimeric mouse-human monoclonal IgG antibody against human respiratory syncitial virus infection.Combined ribavarin-palivizumab therapy is being evaluated for immunosuppressed children with HRSV pneumonia. Ref:Harrison's medicine-19th edition,page no:1206.
Rituximab
Palivizumab
none
Omalizurnab
Respiratory system